Zuplenz

Zuplenz is a brand name of ondansetron, approved by the FDA in the following formulation(s):

ZUPLENZ (ondansetron - film; oral)

• 
  Manufacturer: MONOSOL RX LLC
  
  Approval date: July 2, 2010
  
  Strength(s): 4MG, 8MG ^[RLD]

Has a generic version of Zuplenz been approved?

No. There is currently no therapeutically equivalent version of Zuplenz available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zuplenz. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zuplenz.

See also...

• Zuplenz Consumer Information (Drugs.com)
• Zuplenz Soluble Film Consumer Information (Wolters Kluwer)
• Zuplenz Consumer Information (Cerner Multum)
• Zuplenz Advanced Consumer Information (Micromedex)
• Ondansetron Consumer Information (Drugs.com)
• Ondansetron Consumer Information (Wolters Kluwer)
• Ondansetron Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Ondansetron Soluble Film Consumer Information (Wolters Kluwer)
• Ondansetron Solution Consumer Information (Wolters Kluwer)
• Ondansetron Tablets Consumer Information (Wolters Kluwer)
• Ondansetron Consumer Information (Cerner Multum)
• Ondansetron injection Consumer Information (Cerner Multum)
• Ondansetron Oral, Injection, Intravenous Advanced Consumer Information (Micromedex)
• Ondansetron Oral, Oromucosal Advanced Consumer Information (Micromedex)
• Ondansetron Hydrochloride AHFS DI Monographs (ASHP)